Default company panoramic image
82173977 daac 413a 87db f5140cab4581

Advanced Plasma Therapies, Inc

Using plasma energy to deliver the therapeutic benefits of nitric oxide across the skin - safely, effectively and economically.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Lawrence Township, NJ, USA
  • Currency USD
  • Founded June 2010
  • Employees 5
  • Website

Company Summary

We address major unmet medical needs. We are initially targeting (i) skin & soft tissue infections and wound-healing and (ii) pain and inflammation in osteo- and rheumatoid arthritis. We are site-specific, non-systemic and side-effect-free. Significant efficacy has been demonstrated in proof-of-principle studies in the US. Our customers will be hospitals (where, for example, we control MRSA), wound-care clinics and physicians in private practice.


  • Default avatar
    Howard A Nelson

    Ex-Pfizer, Bristol Myers Squibb, Honeywell, Phosphagenics, all in business development. Responsible for in-licensing of major drugs. Latterly specializing in working with young medical technologies. AB from Princeton, MBA from Tulane.

  • Default avatar
    Michael D Preston

    UK Chartered Accountant, ex-Price Waterhouse; founder of many businesses in UK and US, including Sterling Publishing Group, Broad Street Group, Cadiz Land, Inc. Life sciences and biotech experience. Authorized as corporate finance principal by FCA in UK, concentrating in life sciences. BA and MA from Oxford University.

  • Default avatar
    David Dantzker, MD
    Director, Medical Strategy

    Lead director of Advanced BioHealing, a wound therapy venture that was successfully developed and recently sold to Shire for $750 million; General Partner of Wheatley Partners; former President/CEO of North Shore/LIJ Health System, 2nd largest healthcare delivery system in the US; Chairman of the American Board of Internal Medicine


  • Default avatar
    Ellenoff, Grossman & Schole
    Default avatar
    Rosen Seymour Shapss Martin